College of Biomedical Engineering, Sichuan University, No.24, South 1st Section, 1st Ring Road, Chengdu 610064, P. R. China.
ACS Appl Bio Mater. 2022 Jun 20;5(6):2913-2927. doi: 10.1021/acsabm.2c00264. Epub 2022 May 30.
Extracellular matrix (ECM)-based therapies have been developed to improve bone repair because of their abundance of bioactive components. Besides the osteogenic promotion and the immune response, the potential effect of the ECM on the coordination between osteoblastogenesis and osteoclastogenesis in vivo should also deserve great attention because both osteoblasts and osteoclasts get involved in bone regeneration and are critical for the final repair outcome. Herein, based on our previous study on decellularization, antigen removal, and growth factor retention, porous poly (lactic-co-glycolic acid) (PLGA) scaffolds decorated with the bone marrow mesenchymal stem cell (BMSC)-derived ECM were prepared, and the functions of the ECM on BMSC osteogenic differentiation and osteoclastogenesis in vitro were preferentially investigated. Afterward, bone regeneration and osteoclast formation in vivo induced by ECM-decorated PLGA scaffolds were further studied. The in vitro tests revealed that ECM-decorated PLGA scaffolds obviously facilitated BMSC proliferation and osteogenic differentiation. However, when osteoclast precursors were cultured on the BMSC-derived ECM, the number and size of osteoclasts, expression of cathepsin K and matrix metalloproteinase 9, and tartrate-resistant acid phosphatase activity were notably decreased, accompanied by the reduction in the reactive oxygen species (ROS) level. Interestingly, the addition of exogenous hydrogen peroxide elevated the osteoclast amount on the ECM and up-regulated the resorption-related enzyme levels, implying that the repressive effect of the BMSC-derived ECM on osteoclasts may be related to the intracellular ROS. After implantation into calvarial defects, the ECM-decorated PLGA scaffolds significantly increased bone volume and bone mineral density compared with bare PLGA scaffolds and did not stimulate the overmuch formation of osteoclasts in vivo. This study evidenced that the BMSC-derived ECM may coordinate osteoblastogenesis and osteoclastogenesis and promote favorable bone formation without stimulating bone resorption.
基于细胞外基质 (ECM) 的疗法已被开发用于改善骨修复,因为它们含有丰富的生物活性成分。除了促进成骨和免疫反应外,ECM 对体内成骨细胞和破骨细胞之间协调的潜在影响也应引起高度重视,因为成骨细胞和破骨细胞都参与骨再生,并且对最终修复结果至关重要。在此,基于我们之前关于脱细胞、抗原去除和生长因子保留的研究,制备了骨髓间充质干细胞 (BMSC) 衍生的细胞外基质修饰的多孔聚 (乳酸-共-乙醇酸) (PLGA) 支架,并优先研究了细胞外基质对 BMSC 成骨分化和体外破骨细胞分化的作用。随后,进一步研究了细胞外基质修饰的 PLGA 支架在体内的骨再生和破骨细胞形成作用。体外试验表明,细胞外基质修饰的 PLGA 支架明显促进了 BMSC 的增殖和成骨分化。然而,当破骨细胞前体在 BMSC 衍生的细胞外基质上培养时,破骨细胞的数量和大小、组织蛋白酶 K 和基质金属蛋白酶 9 的表达以及抗酒石酸酸性磷酸酶活性明显降低,同时伴随着活性氧 (ROS) 水平的降低。有趣的是,添加外源性过氧化氢会增加细胞外基质上的破骨细胞数量,并上调吸收相关酶水平,这表明 BMSC 衍生的细胞外基质对破骨细胞的抑制作用可能与细胞内 ROS 有关。植入颅骨缺损后,与 bare PLGA 支架相比,细胞外基质修饰的 PLGA 支架显著增加了骨量和骨矿物质密度,并且在体内没有刺激过多的破骨细胞形成。这项研究表明,BMSC 衍生的细胞外基质可能协调成骨细胞和破骨细胞的形成,并促进有利的骨形成,而不会刺激骨吸收。